Cardiac Resynchronization Therapy (CRT) is an established therapy to treat Heart Failure patients. As CRT devices become more sophisticated, it is now possible to program settings to optimize cardiac function for each individual patient.
BMEYE's technology can bring great benefits to the individual optimization of CRT devices. It is estimated that one-third of the patients with an implanted CRT device don't benefit from it (non-responders), partly because the settings of CRT devices are not optimized to the patient's individual needs. The main barrier to perform CRT optimization procedures is that, until now, available technologies were complicated and time-consuming. With the Nexfin monitor, cardiologists and pacemaker technicians can track changes in stroke volume quickly, in real-time, and with a single operator.
In addition to CRT optimization, BMEYE's technology available in Nexfin is ideal for accurately diagnosing syncope. Nexfin can monitor beat-to-beat blood pressure and ECG totally non-invasively, making it an ideal tool for complementing tilt-table tests.
Finally, thanks to its non-invasiveness and ease-of-use, our technology has a wide variety of applications ranging from interventional electrophysiology labs and Coronary Care Units (CCU) to exercise testing.